The Pharmaceutical Quality System (ICH Q10)
ICH Q10 describes a comprehensive model for an effective pharmaceutical quality system (PQS) across the entire product lifecycle, built on ISO quality-management concepts, GMP, and ICH Q8 and Q9. It is the system that holds every other discipline together — the thing an inspector means when they refer to "your quality system".
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 23 LINKSThe PQS is the QMS discipline’s anchor subject: one quality system spanning development, transfer, commercial manufacturing, and discontinuation, whose four ICH Q10 elements map directly onto the capabilities row below.
06 · QUALITY MATURITY — THE PHARMACEUTICAL QUALITY SYSTEM (ICH Q10), REACTIVE TO ADAPTIVE
The quality system is an SOP binder that wakes up at commercial manufacture; problems repeat because nothing connects them.
The four Q10 elements exist as separate procedures; monitoring, CAPA, change, and review run without feeding each other.
The elements interlock: monitoring signals drive CAPA, fixes land through change management, and review governs the loop.
Management review works from leading indicators; knowledge carries across the lifecycle instead of being rebuilt per stage.
The PQS drives lifecycle decisions and continual improvement, with senior management visibly owning quality outcomes.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 4
Derived from the 4 standards SPEQ maps to this subject, across 3 regulatory bodies: FDA, ICH, ISO.
RECORDS & OBJECTIVE EVIDENCE
- A quality manual and quality policy owned by senior management
- Management review minutes with tracked actions and outcomes
- CAPA records with root-cause analysis and effectiveness checks
- Change records with cross-functional impact assessment
- Periodic product quality reviews trending process performance
COMMON INSPECTION FINDINGS
- Management review held rarely, or without tracked actions
- CAPA effectiveness never verified after implementation
- Recurring deviations with no systemic corrective action
- A quality unit without the authority or resources its duties require
- Monitoring signals that never reach CAPA or management review
One system, the whole lifecycle
The defining idea of ICH Q10 is lifecycle scope. The same quality system spans pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation — so knowledge and control carry forward rather than being rebuilt at each stage. A quality system that only wakes up at commercial manufacturing has already lost the development knowledge that makes control possible.
The four elements
Q10 names four elements that operate across the lifecycle: a process performance and product quality monitoring system; a corrective action and preventive action (CAPA) system; a change management system; and management review of process performance and product quality. These are the machinery of a working PQS — the parts that turn "we have procedures" into "we are demonstrably in control".
Crucially they interlock: monitoring surfaces signals, CAPA acts on them, change management implements the fix under control, and management review governs the whole loop. A gap in any one weakens the others.
The two enablers — knowledge management and QRM
Two enablers run underneath everything: knowledge management (capturing and using product and process knowledge across the lifecycle) and quality risk management (ICH Q9). They are what make the four elements intelligent rather than mechanical — risk decides where to focus, and knowledge makes each decision better than the last.
Management responsibility
ICH Q10 places senior management explicitly on the hook: for the quality policy, for resources, for the quality system’s design and effectiveness, and for management review. This is the same leadership-ownership theme FDA’s Quality Management Maturity program frames as Management Commitment — a PQS is only as real as the leadership behind it.
PQS and ISO 9001
ICH Q10 is built on ISO 9001 quality-management principles but is pharma-specific and GMP-anchored — it augments GMP rather than replacing it, and it reaches into development where GMP does not. A firm can hold ISO 9001 certification and still need a Q10-compliant PQS; the two are complementary, not interchangeable.
WORKED EXAMPLE — SPEQ SYNTHESIS
A hypothetical growing manufacturer has procedures, a quality unit, and a deviation system that works. Its management review is a quarterly slide pack summarising counts of deviations, CAPAs and complaints. An assessor asks what decisions the last four reviews produced.
Notice that reporting and governing are different activities
Counts describe the period. A management review exists to produce decisions and allocate resources, and a review whose output is a filed deck has performed the first activity while appearing to perform the second.
Choose indicators that say something about system health
A stable deviation count with rising average age is a deteriorating system that a count conceals. Ageing, overdue proportion, recurrence by cause and time-to-closure carry information; totals mostly do not.
Carry prior actions forward until they close
Each review should open with the state of the last one’s actions. A review that restates open items without ageing them is where actions go to be re-noted indefinitely.
Bring the trends no single product or site review can see
Cross-product and cross-site patterns — a supplier appearing in three unrelated investigations, a training gap showing up on two lines. These are exactly the signals the quality system exists to surface and the only forum able to see them.
Record decisions, owners, dates and resources in the words used
An action without a named owner and a resource commitment is a decision not taken. Writing it down as it was said is also what protects the review from being reconstructed later as more decisive than it was.
Close the loop back into the system
The improvements agreed have to appear in the change, CAPA or training systems where work actually happens. A management review that terminates in its own minutes is a governance layer disconnected from the thing it governs.
A review producing a live action register with ageing, a stable indicator set chosen for signal rather than convenience, cross-cutting trends visible nowhere else, and decisions carrying owners and resources into the operational systems. Whether the quality system is effective is the organisation’s judgement, made with this as its instrument.
WHAT WOULD CHANGE THIS
- A single-product start-up has too little data for trending, and the honest review leans on qualification status and open risks instead — with the limitation stated rather than filled with thin trends.
- If the review’s attendees cannot allocate resources, the sequence above produces decisions nobody can fund, and the fix is the attendee list rather than the agenda.
- A site inside a larger network may hold some of these decisions at network level, in which case the local review should say which ones and where they are taken.
FREQUENTLY ASKED
What is ICH Q10?
ICH Q10 is the international guideline describing a model for an effective Pharmaceutical Quality System across the product lifecycle — development, technology transfer, commercial manufacturing, and discontinuation. It is built on ISO concepts and complements GMP and ICH Q8/Q9.
What are the four elements of the PQS?
A process performance and product quality monitoring system; a CAPA system; a change management system; and management review of process performance and product quality — the four interlocking systems that operate across the lifecycle.
What are the two PQS enablers?
Knowledge management and quality risk management (ICH Q9). They run underneath the four elements — risk directs effort, and knowledge carried across the lifecycle makes each quality decision better than the last.
How does ICH Q10 relate to ISO 9001?
ICH Q10 is founded on ISO 9001 quality-management principles but is pharmaceutical-specific and anchored to GMP, extending into development. Holding ISO 9001 does not by itself satisfy Q10; the two are complementary.